Kane Biotech Inc. (Kane) is a Canada-based company engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company�s technologies include DispersinB, Aledex, StrixNB and KBI Antibacterial Disinfectant (KBI). Kane�s technology for the wound care market is DispersinB. The Company has a number of DispersinB formulations in development, including formulations with antibiotics and the antibiofilm enzyme B-N-Acetylglucosaminidase. Kane has developed antibiofilm-antimicrobial formulations for both the veterinary and human markets. The Aledex is used in medical device coating market. The KBI contains antimicrobial-antibiofilm combination consists of Chlorhexidine (CHX) and Sodium Metaperiodate (SMP). The StrixNB is used for the oral care market.